Collective vs MEDVi: Which GLP-1 Provider Is Better?
Short answer: MEDVi scores higher on our rubric, 5.7/10 against 4.6/10. Full reasoning, pricing and the cases where the other one wins are below.
MEDVi beats Collective overall, scoring 5.7/10 vs 4.6/10. Published pricing is not a like-for-like monthly comparison: Collective is from $59/mo; MEDVi is $179 first month, then $299/mo. Choose Collective for cash-pay patients planning to stay in treatment long enough for the low flat medication rate to offset the required annual membership. Choose MEDVi for users who want both oral and injectable compounded options in one telehealth program.
A side-by-side look at Collective and MEDVi to help you decide. We compare them on:
- •Starting price and billing period
- •Our overall score, out of 10
- •Medication type, brand-name or compounded
- •Whether they accept insurance
- •Who each one is best for
Collective
#32 of 36CollectiveOS is a membership telehealth platform operated by Health For Everyone Inc. It advertises compounded semaglutide at $59 a month and compounded tirzepatide at $69 a month, with the same medication price at every dose and no multi-month medication commitment. The required membership is free for 21 days and then costs $199 a year. That makes the first-year cash totals $907 for semaglutide and $1,027 for tirzepatide before any technology transaction fee that the terms permit but do not price. Membership includes clinician review, unlimited doctor messaging, nutrition and lifestyle support, and two-day express cold shipping. Collective links to LegitScript's public checker and identifies MDIntegrations as an example clinician network, but it does not publicly name a dispensing pharmacy or list the states it serves.
Visit CollectiveMEDVi
#25 of 36MEDVi offers a weekly compounded GLP-1 injection and a daily compounded tablet. The injection is $179 for month one and $299 for refills. Trustpilot is 4.3 out of 5 across 14,680 reviews, while BBB is F/not accredited. FDA warning letter #721455 concerns misleading labeling and marketing, not an allegation that the medication was unsafe.
Visit MEDVi| Feature | Collective | MEDVi |
|---|---|---|
| Why each one | Very low month-to-month medication pricing that remains flat across doses, funded through a separately disclosed annual membership. | A daily dissolvable GLP-1 tablet and a weekly compounded injection in one program, plus brand-name Wegovy and Zepbound on a $99 membership. |
| Our Score | 4.6/10 | 5.7/10 |
| Headline Price | from $59/mo | $179 first month, then $299/mo |
| Medication Type | Compounded | Both |
| Insurance Accepted | Cash-pay. Collective says medication and membership are HSA/FSA eligible; eligibility and reimbursement depend on the account and expense. | No |
| Best For | Cash-pay patients planning to stay in treatment long enough for the low flat medication rate to offset the required annual membership | Users who want both oral and injectable compounded options in one telehealth program |
| Watch out for | The $59 and $69 medication headlines exclude a required $199 annual membership after a 21-day trial | FDA warning letter #721455, issued February 20, 2026, cites misleading labeling and marketing that implied MEDVi compounded the drugs and that compounded products were equivalent to or FDA-evaluated like approved brands. The letter does not allege unsafe medication |
| Ranking | #32 | #25 |
| Get started | Visit Collective | Visit MEDVi |
Pros & Cons Compared
Collective
Pros
- +$59/mo compounded semaglutide and $69/mo compounded tirzepatide, with the medication price advertised as flat at every dose
- +Medication is billed month to month rather than through a required multi-month medication prepayment
- +Two-day express cold shipping, clinician review, unlimited doctor messaging, and nutrition and lifestyle support are included
- +The public site links certificate 50716874 to LegitScript's verification checker
- +The legal entity and MDIntegrations clinician-network relationship are disclosed in the legal pages
Cons
- −The $59 and $69 medication headlines exclude a required $199 annual membership after a 21-day trial
- −The terms permit a nominal technology transaction fee for each electronic prescription but publish no amount
- −No dispensing pharmacy, individual clinician, medical director, or public state-availability list is named
- −The annual membership auto-renews and is generally non-refundable, with no partial-period refunds
- −Only 9 Trustpilot reviews at 4.1/5 when checked September 15, 2026, too few for a mature reputation signal
- −Cash-pay compounded medications only; no brand-name Wegovy or Zepbound and no insurance or prior-authorization service
MEDVi
Pros
- +One of the few compounded providers offering both oral tablets and injectable semaglutide
- +The landing page says the program is HSA and FSA eligible and includes dietician visits and care coaching, with a footnote making that subject to insurance and copay eligibility
- +Sleek onboarding experience with clear progress tracking through their patient portal
- +$179 covers the first month of compounded semaglutide on MEDVi's landing page, including physician review, the personalized plan, medication and free shipping
Cons
- −FDA warning letter #721455, issued February 20, 2026, cites misleading labeling and marketing that implied MEDVi compounded the drugs and that compounded products were equivalent to or FDA-evaluated like approved brands. The letter does not allege unsafe medication
- −Its third-party records conflict: 4.3 out of 5 across 14,680 Trustpilot reviews with 12 percent of them at one star, against an F and no accreditation at the BBB
- −The $179 semaglutide price covers month one only; the FAQ on MEDVi's own landing page says refills are locked in at $299 a month, making the first year $3,468 rather than $2,148
- −Brand-name Wegovy and Zepbound paths add a $99 membership plus a medication cost the page does not publish, and the same page's hero says "No membership or hidden fees!" directly above those cards; availability is subject to change
- −No insurance accepted, and oral compounded semaglutide has less clinical data than injectable forms
Our Verdict
MEDVi edges out Collective with a score of 5.7/10 vs 4.6/10. Published pricing is not a like-for-like monthly comparison: Collective is from $59/mo; MEDVi is $179 first month, then $299/mo. MEDVi offers both brand-name and compounded medications, giving you more flexibility.
Reviews and pricing sources
Related comparisons
More head-to-head comparisons involving Collective and MEDVi.
Not comparing, just asking? Quick answers to the most-asked GLP-1 questions →
- Compare Collective and Oak Longevityfrom $167/mo
- Compare Collective and Bodybuilding Health+$179/mo month-to-month
- Compare Collective and Trimi Health$175/mo month-to-month
- Compare MEDVi and Oak Longevityfrom $167/mo
- Compare MEDVi and Bodybuilding Health+$179/mo month-to-month
- Compare MEDVi and Trimi Health$175/mo month-to-month
Not sure which one is right for you?
Answer a few quick questions and we'll match you to the best GLP-1 provider for your needs. Or keep exploring below.
Still working out whether either one is above board? We check that separately: is Collective legit and is MEDVi legit, with the verification evidence behind each answer.
Our pick of these two: MEDVi · 5.7/10